Meeting Coverage

HFSA

Heart Failure Society of America

Mavacamten Shows Promise in Heart Failure With Normal to Supranormal EF

Cardiac myosin inhibitor linked to improvements in biomarkers in small study

HFSA over a computer rendering of the human heart.

Latest HFSA Meeting Coverage

Case Strengthens for Cardiac Myosin Inhibitor in SEQUOIA-HCM

Vast majority of trial participants responded to aficamten

September 30, 2024
Does Finerenone's Efficacy Diminish If Initiated Late in Heart Failure?

Benefit of the nonsteroidal MRA otherwise consistent across FINEARTS-HF

September 29, 2024
Novel Nerve Ablation Procedure Explored for HFpEF

Splanchnic nerve ablation for volume management passes a feasibility hurdle

October 11, 2023
Copper-Boosting Agent Promising for Low Ejection Fraction Heart Failure

Early-phase study analysis suggests potential for remodeling

October 10, 2023
Modest Risks Come With Moving Fast on HF Drugs After Acute Event

STRONG-HF analysis details the impact

October 10, 2023
Vagus Nerve Stimulation in Limbo for HFrEF

Autonomic regulation therapy trial showed signal for benefit in terminated pivotal trial

October 9, 2023
Biomarker-Based CardioMEMS Candidates Still Benefit

GUIDE-HF trial analysis distinguishes "strata" with different levels of risk

October 9, 2023
FDA Turns Down ATTR Cardiomyopathy Drug

Decision cites insufficient evidence of clinical meaningfulness

October 9, 2023
Weight-Loss Drug Benefit Spans HFpEF, HFmrEF

STEP-HFpEF trial results come out consistent across ejection fraction

October 8, 2023
Salt Pills During Diuresis: Acute HF Patients Neither Helped Nor Harmed

Small randomized trial challenges conventional thinking about sodium

October 5, 2022
Concurrent LAA Occlusion Loses Its Appeal for LVAD Surgeons

Heart pump placement plus anticoagulation suffice for patients, even those with Afib

October 5, 2022
The Search Is On for Another Xeno Heart Transplant Recipient

Transplant surgeons discuss testing the concept in more humans

October 4, 2022
Urgency to Expand SGLT2i Use in HF Heightened by More DELIVER Data

Analyses continue to support wider adoption of dapagliflozin, researchers say

October 3, 2022
UNOS to Revamp Heart Allocation Rules to Rein in Transplant Waitlist Tricks

It may be goodbye to priority tiers, hello to points-based ranking system in coming years

October 3, 2022